Home Sitemap

About CASCADE

CASCADE was established in 1997, and is a collaboration between the investigators of 25 cohorts of persons with well-estimated dates of HIV seroconversion (seroconverters).

It is currently a network of epidemiologists, statisticians, virologists and clinicians from lead HIV institutions in 15 European countries, as well as Australia, Canada, and Africa.

Seroconverters are enrolled into the individual cohorts locally and nationally and are typically followed up life-long.

CASCADE’s main aim is to monitor newly infected individuals and those already enrolled in studies, covering the entire duration of HIV infection.

The main premise is that through pooling data we are able to address issues that cannot be reliably addressed from single studies alone.

Further details about CASCADE


CASCADE brochure now available to download

The CASCADE brochure showcases just some of the many research achievements of CASCADE during the recent funding term 2006-2010.

If you would like a hard copy of the brochure, please contact the Study Coordinator.  


Download the CASCADE brochure

right

Latest news

No evidence of clinical benefit for patients starting treatment with a healthy immune system
 
A paper published by the CASCADE Collaboration in EuroCoord has found no evidence of clinical benefit for patients starting HIV treatment at higher CD4 cell counts of between 500-799 cells/mm³.

arrowRead the full story


Steering Committee

Julia Del Amo (Chair)
Laurence Meyer (Vice Chair)
Heiner Bucher
Genevičve Chęne
Osamah Hamouda
Deenan Pillay
Maria Prins
Magda Rosinska
Caroline Sabin
Giota Touloumi

Co-ordinating Centre

Abdel Babiker
Ashley Olson
Sarah Walker
Kate Coughlin

Project Leader: Kholoud Porter